During the past decade, Heart Care Research Foundation conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 6 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Heart Care Research Foundation" #1 sponsor was "Pfizer" with 2 trials, followed by "W.L.Gore & Associates" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored, "Baim Institute for Clinical Research" with 1 trials sponsored and "Boston Scientific Corporation" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Heart Care Research Foundation" #1 collaborator was "Abbott" with 1 trials as a collaborator, "Boston Scientific Corporation" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Cordis Corporation" with 1 trials as a collaborator and "Daiichi Sankyo, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Heart Care Research Foundation" are "Cardiovascular Disease" (2 trials), "Coronary Artery Disease" (2 trials), "Arterial Occlusive Diseases" (1 trials), "Atherosclerosis" (1 trials) and "Brain Diseases" (1 trials). Many other conditions were trialed in "Heart Care Research Foundation" in a lesser frequency.

Most popular intervention types in "Heart Care Research Foundation" are "Device" (3 trials) and "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "bococizumab (PF-04950615)" (2 trials), "ACUITY Spiral Left Ventricular Lead" (1 trials), "BARD LifeStent" (1 trials) and "Clopidogrel & Aspirin, Prasugrel & Aspirin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Heart Care Research Foundation" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Heart Care Research Foundation". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Heart Care Research Foundation, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Heart Care Research Foundation, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".

Heart Care Research Foundation has several departments that took part in Clinical trials: "Heart Care Research Foundation" - 2 trials